中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

磁共振磁敏感加权成像在肝硬化结节多步癌变中的临床应用

曾蒙苏 李若坤

引用本文:
Citation:

磁共振磁敏感加权成像在肝硬化结节多步癌变中的临床应用

详细信息
  • 中图分类号: R735.7

Clinical value of susceptibility-weighted imaging for studying the multi-step hepatocarcinogenic process of cirrhotic liver nodules

  • 摘要:

    肝癌早期发现,早期治疗,明显提高5年生存率。肝硬化患者,绝大部分均经历肝硬化结节多步癌变的过程,即由再生结节发展为异型增生结节,其中高分化异型增生结节发展为癌变结节后(早期肝癌),再发展为小肝癌,小肝癌最后发展成进展期或晚期肝癌。上述结节的一系列变化过程中,其结节内内源性铁逐步廓清,本文重点介绍利用磁共振磁敏感加权成像(SWI)技术观察结节中内源性铁变化情况,同时结合常规MR T2WI、弥散加权成像(DWI)和动态增强等技术,提高识别肝硬化背景下的癌变/早期肝癌结节能力,从而对进一步提高早期小肝癌的诊疗,具有更重要的临床意义。

     

  • [1] Sherman M. Epidemiology of hepatocellular carcinoma[J]. Oncology, 2010, 78 (Suppl 1) : 7-10.
    [2]Benvegnu L, Gios M, Boccato S, et al.Natural history ofcompensated viral cirrhosis:a prospective study on inci-dence and hierarchy of major complications[J].Gut, 2004, 53 (5) :744-749.
    [3]Kim YS, Um SH, Ryu HS, et al.The prognosis of liver cir-rhosis in recent years in Korea[J].J Korean Med Sci, 2003, 18 (6) :833-841.
    [4] Planas R, Balleste B, Alvarez MA, et al. Natural history of decompensated hepatitis C virus-related cirrhosis. Study of 200 patients[J]. J Hepatol, 2004, 40 (5) : 823-830.
    [5]Hytiroglou P, Park YN, Krinsky G, et al.Hepatic precancer-ous lesions and small hepatocellular carcinoma[J].Gastro-enterol Clin North Am, 2007, 36 (4) :867-887.
    [6] Hanna RF, Aguirre DA, Kased N, et al. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features[J]. Radiographics, 2008, 28 (3) : 747-769.
    [7]Shinmura R, Matsui O, Kobayashi S, et al.Cirrhotic nodules:association between MR imaging signal intensity and intranodu-lar blood supply[J].Radiology, 2005, 237 (2) :512-519.
    [8]Park YN.Update on precursor and early lesions of hepatocel-lular carcinomas[J].Arch Pathol Lab Med, 2011, 135 (6) :704-715.
    [9]Kim MJ.Current limitations and potential breakthroughs forthe early diagnosis of hepatocellular carcinoma[J].Gut Liv-er, 2011, 5 (1) :15-21.
    [10]Ludwig J, Hashimoto E, Porayko MK, et al.Hemosiderosisin cirrrhosis, a study of 447 native livers[J].Gastroenterolo-gy, 1997, 112 (3) :882-888.
    [11] Zhang JB, Krinsky GA. Iron-containing nodules of cirrhosis[J]. NMR Biomed, 2004, 17 (7) : 459-464.
    [12]Terada T, Kadoya M, Nakanuma Y, et al.Iron-accumulatingadenomatous hyperplastic nodule with malignant foci in thecirrhotic liver.Histopathologic, quantitative iron, and mag-netic resonance imaging in vitro studies[J].Cancer, 1990, 65 (9) :1994-2000.
    [13]Terada T, Nakanuma Y.Iron-negative foci in siderotic mac-roregenerative nodules in human cirrhotic liver.A marker ofincipient neoplastic lesions[J].Arch Pathol Lab Med, 1989, 113 (8) :916-920.
    [14]Honda H, Kaneko K, Kanazawa Y, et al.Imaging of hepato-cellular carcinomas:effect of Cu and Fe contents on signalintensity[J].Abdom Imaging, 1997, 22 (1) :60-66.
    [15] Pascale RM, De Miglio MR, Muroni MR, et al. Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat[J]. Hepatology, 1998, 27 (2) : 452-461.
    [16] Lee AW, Oates PS, Trinder D. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells[J]. Hepatology, 2003, 38 (4) : 967- 977.
    [17]Tan MG, Kumarasinghe MP, Wang SM, et al.Modulation ofiron-regulatory genes in human hepatocellular carcinomaand its physiological consequences[J].Exp Biol Med (May-wood) , 2009, 234 (6) :693-702.
    [18]Holmstr m P, Gafvels M, Eriksson LC, et al.Expression ofiron regulatory genes in a rat model of hepatocellular carcino-ma[J].Liver International, 2006, 26 (8) :976-985.
    [19]Haacke EM, Xu YB, Cheng YC, et al.Susceptibility weigh-ted imaging (SWI) [J].MRM, 2004, 52 (3) :612-618.
    [20]Thomas B, Somasundaram S, Thamburaj, et al.Clinical applica-tions of susceptibility-weighted imaging of the brain-a pictori-al review[J].Neuroradiology, 2008, 50 (2) :105-116.
    [21] Haacke EM, Mittal S, Wu Z, et al. Susceptibility weighted imaging: technical ascepts and clinical applications, part 1[J]. AJNR Am J Neuradiol, 2009, 30 (1) : 19-30.
    [22] Haacke EM, Mittal S, Wu Z, et al. Susceptibility weighted imaging: technical ascepts and clinical applications, part 2[J]. AJNR Am J Neuradiol, 2009, 30 (2) : 232- 252.
    [23]Yu JS, Chung JJ, Kim JH, et al.Small hypervascular hepa-tocellular carcinomas:value of“washout”on gadolinium-enhanced dynamic MR imaging compared to superparamag-netic iron oxide-enhanced imaging[J].Eur Radiol, 2009, 19 (11) :2614-2622.
    [24]Yoo HJ, Lee JM, Lee MW, et al.Hepatocellular carcinomain cirrhotic liver:double-contrast-enhanced, high-resolu-tion 3.0T-MR imaging with pathologic correlation[J].In-vest Radiol, 2008, 43 (7) :538-546.
    [25]Chung YE, Park MS, Kim MS, et al.Quantification of super-paramagnetic iron oxide-mediated signal intensity change inpatients with liver cirrhosis using T2 and T2*mapping:apreliminary report[J].Magn Reson Imaging, 2010, 31 (6) :1379-1386.
  • 加载中
计量
  • 文章访问数:  3322
  • HTML全文浏览量:  18
  • PDF下载量:  725
  • 被引次数: 0
出版历程
  • 出版日期:  2013-01-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回